These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 32047208)

  • 1. A novel de novo variant of GABRA1 causes increased sensitivity for GABA in vitro.
    Steudle F; Rehman S; Bampali K; Simeone X; Rona Z; Hauser E; Schmidt WM; Scholze P; Ernst M
    Sci Rep; 2020 Feb; 10(1):2379. PubMed ID: 32047208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathophysiology of and therapeutic options for a GABRA1 variant linked to epileptic encephalopathy.
    Bai YF; Chiu M; Chan ES; Axerio-Cilies P; Lu J; Huh L; Connolly MB; Guella I; Farrer MJ; Xu ZD; Liu L; Demos M; Wang YT
    Mol Brain; 2019 Nov; 12(1):92. PubMed ID: 31707987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. De novo variants in GABRA2 and GABRA5 alter receptor function and contribute to early-onset epilepsy.
    Butler KM; Moody OA; Schuler E; Coryell J; Alexander JJ; Jenkins A; Escayg A
    Brain; 2018 Aug; 141(8):2392-2405. PubMed ID: 29961870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered inhibitory synapses in de novo GABRA5 and GABRA1 mutations associated with early onset epileptic encephalopathies.
    Hernandez CC; XiangWei W; Hu N; Shen D; Shen W; Lagrange AH; Zhang Y; Dai L; Ding C; Sun Z; Hu J; Zhu H; Jiang Y; Macdonald RL
    Brain; 2019 Jul; 142(7):1938-1954. PubMed ID: 31056671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct Functional Alterations and Therapeutic Options of Two Pathological De Novo Variants of the T292 Residue of GABRA1 Identified in Children with Epileptic Encephalopathy and Neurodevelopmental Disorders.
    Chen W; Ge Y; Lu J; Melo J; So YW; Juneja R; Liu L; Wang YT
    Int J Mol Sci; 2022 Mar; 23(5):. PubMed ID: 35269865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The de novo missense mutation F224S in GABRB2, identified in epileptic encephalopathy and developmental delay, impairs GABA
    Li PP; Zhou YY; Gao L; Lv JN; Xu SS; Zhao YW; Xu D; Huang R; Zhang X; Li P; Fu X; He Z
    Neuroscience; 2024 Aug; 553():172-184. PubMed ID: 38964454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. De novo variants in GABRA4 are associated with a neurological phenotype including developmental delay, behavioral abnormalities and epilepsy.
    Sajan SA; Gradisch R; Vogel FD; Coffey AJ; Salyakina D; Soler D; Jayakar P; Jayakar A; Bianconi SE; Cooper AH; Liu S; William N; Benkel-Herrenbrück I; Maiwald R; Heller C; Biskup S; Leiz S; Westphal DS; Wagner M; Clarke A; Stockner T; Ernst M; Kesari A; Krenn M
    Eur J Hum Genet; 2024 Aug; 32(8):912-919. PubMed ID: 38565639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rare GABRA3 variants are associated with epileptic seizures, encephalopathy and dysmorphic features.
    Niturad CE; Lev D; Kalscheuer VM; Charzewska A; Schubert J; Lerman-Sagie T; Kroes HY; Oegema R; Traverso M; Specchio N; Lassota M; Chelly J; Bennett-Back O; Carmi N; Koffler-Brill T; Iacomino M; Trivisano M; Capovilla G; Striano P; Nawara M; Rzonca S; Fischer U; Bienek M; Jensen C; Hu H; Thiele H; Altmüller J; Krause R; May P; Becker F; ; Balling R; Biskup S; Haas SA; Nürnberg P; van Gassen KLI; Lerche H; Zara F; Maljevic S; Leshinsky-Silver E
    Brain; 2017 Nov; 140(11):2879-2894. PubMed ID: 29053855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. De Novo Missense Variants in SLC32A1 Cause a Developmental and Epileptic Encephalopathy Due to Impaired GABAergic Neurotransmission.
    Platzer K; Sticht H; Bupp C; Ganapathi M; Pereira EM; Le Guyader G; Bilan F; Henderson LB; Lemke JR; Taschenberger H; Brose N; Abou Jamra R; Wojcik SM
    Ann Neurol; 2022 Dec; 92(6):958-973. PubMed ID: 36073542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular analysis of the A322D mutation in the GABA receptor alpha-subunit causing juvenile myoclonic epilepsy.
    Krampfl K; Maljevic S; Cossette P; Ziegler E; Rouleau GA; Lerche H; Bufler J
    Eur J Neurosci; 2005 Jul; 22(1):10-20. PubMed ID: 16029191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical phenotypes of epilepsy associated with GABRA1 gene variants].
    Yang Y; Zhang YH; Chen JY; Ma JH; Sun D; Yang XL; Zhang J; Chen Y; Wu XR
    Zhonghua Er Ke Za Zhi; 2020 Feb; 58(2):118-122. PubMed ID: 32102148
    [No Abstract]   [Full Text] [Related]  

  • 12. Structural analysis of pathogenic missense mutations in GABRA2 and identification of a novel de novo variant in the desensitization gate.
    Sanchis-Juan A; Hasenahuer MA; Baker JA; McTague A; Barwick K; Kurian MA; Duarte ST; ; Carss KJ; Thornton J; Raymond FL
    Mol Genet Genomic Med; 2020 Jul; 8(7):e1106. PubMed ID: 32347641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two different mechanisms of disinhibition produced by GABAA receptor mutations linked to epilepsy in humans.
    Bianchi MT; Song L; Zhang H; Macdonald RL
    J Neurosci; 2002 Jul; 22(13):5321-7. PubMed ID: 12097483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular and clinical descriptions of patients with GABA
    Maillard PY; Baer S; Schaefer É; Desnous B; Villeneuve N; Lépine A; Fabre A; Lacoste C; El Chehadeh S; Piton A; Porter LF; Perriard C; Wardé MA; Spitz MA; Laugel V; Lesca G; Putoux A; Ville D; Mignot C; Héron D; Nabbout R; Barcia G; Rio M; Roubertie A; Meyer P; Paquis-Flucklinger V; Patat O; Lefranc J; Gerard M; ; de Bellescize J; Villard L; De Saint Martin A; Milh M
    Epilepsia; 2022 Oct; 63(10):2519-2533. PubMed ID: 35718920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations linked to generalized epilepsy in humans reduce GABA(A) receptor current.
    Macdonald RL; Bianchi MT; Feng H
    Exp Neurol; 2003 Nov; 184 Suppl 1():S58-67. PubMed ID: 14597328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GABRB3 mutation, G32R, associated with childhood absence epilepsy alters α1β3γ2L γ-aminobutyric acid type A (GABAA) receptor expression and channel gating.
    Gurba KN; Hernandez CC; Hu N; Macdonald RL
    J Biol Chem; 2012 Apr; 287(15):12083-97. PubMed ID: 22303015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The dual modulatory effects of efavirenz on GABA
    Huang R; Chen Z; Dolan S; Schetz JA; Dillon GH
    Neuropharmacology; 2017 Jul; 121():167-178. PubMed ID: 28456686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. De novo GABRA1 mutations in Ohtahara and West syndromes.
    Kodera H; Ohba C; Kato M; Maeda T; Araki K; Tajima D; Matsuo M; Hino-Fukuyo N; Kohashi K; Ishiyama A; Takeshita S; Motoi H; Kitamura T; Kikuchi A; Tsurusaki Y; Nakashima M; Miyake N; Sasaki M; Kure S; Haginoya K; Saitsu H; Matsumoto N
    Epilepsia; 2016 Apr; 57(4):566-73. PubMed ID: 26918889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered kinetics and benzodiazepine sensitivity of a GABAA receptor subunit mutation [gamma 2(R43Q)] found in human epilepsy.
    Bowser DN; Wagner DA; Czajkowski C; Cromer BA; Parker MW; Wallace RH; Harkin LA; Mulley JC; Marini C; Berkovic SF; Williams DA; Jones MV; Petrou S
    Proc Natl Acad Sci U S A; 2002 Nov; 99(23):15170-5. PubMed ID: 12415111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotypic spectrum of GABRA1: From generalized epilepsies to severe epileptic encephalopathies.
    Johannesen K; Marini C; Pfeffer S; Møller RS; Dorn T; Niturad CE; Gardella E; Weber Y; Søndergård M; Hjalgrim H; Nikanorova M; Becker F; Larsen LH; Dahl HA; Maier O; Mei D; Biskup S; Klein KM; Reif PS; Rosenow F; Elias AF; Hudson C; Helbig KL; Schubert-Bast S; Scordo MR; Craiu D; Djémié T; Hoffman-Zacharska D; Caglayan H; Helbig I; Serratosa J; Striano P; De Jonghe P; Weckhuysen S; Suls A; Muru K; Talvik I; Talvik T; Muhle H; Borggraefe I; Rost I; Guerrini R; Lerche H; Lemke JR; Rubboli G; Maljevic S
    Neurology; 2016 Sep; 87(11):1140-51. PubMed ID: 27521439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.